- Dr. Laxmi Shrikhande is a medical director and chairperson of several organizations focused on obstetrics and gynecology in India.
- She has received numerous national awards for her work in women's health issues like the Nagpur Ratan Award and the Bharat Excellence Award.
- The document discusses diabetes in pregnancy, including the types of diabetes (pre-existing vs. gestational), prevalence, pathophysiology, screening and diagnostic criteria, management, and monitoring during pregnancy.
- Key aspects of managing gestational diabetes include medical nutrition therapy, exercise, self-monitoring of blood glucose, glycemic targets, fetal monitoring, and insulin treatment if needed to control blood sugar
Identifying women with GDM is important because appropriate therapy can decrease maternal and fetal morbidity .
Can prevent two generations from developing diabetes in the future.
Identifying women with GDM is important because appropriate therapy can decrease maternal and fetal morbidity .
Can prevent two generations from developing diabetes in the future.
Welcome to "Gestational Diabetes Mellitus (GDM): What Every Obstetrician Should Know"
Overview of the presentation's objectives and key topics to be covered
Welcome to "Gestational Diabetes Mellitus (GDM): What Every Obstetrician Should Know"
Overview of the presentation's objectives and key topics to be covered
This talk was delivered for postgraduates and faculty of Dr. TMA Pai Hospital, Udupi on 07 March, 2017. This talk covered pathophysiology, screening, diagnosis, complications and management of diabetes mellitus in pregnancy.
Our aim is to reduce morbidity and mortality related to Non communicable diseases such as hypertension, diabetes, cardiovascular disease, stroke, Obesity, Cancer and lifestyle diseases among those least able to withstand the burden of the disease.
Pregestational diabetes a major obstetrical problem now a days. These PPT contains modern as well as Ayurveda aspect for preventing a pregnant women & her baby from developing complications.
Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy and is defined as glucose intolerance that first emerges or is first recognized during pregnancy. Gestational diabetes mellitus (GDM) affects between 2% and 5% of pregnant women. Data show that increasing levels of plasma glucose are associated with birth weight above the 90th percentile, cord blood serum C-peptide level above the 90th percentile, and, to a lesser degree, primary cesarean deliveries and neonatal hypoglycemia
Obesity in Adolescent- Right Time to InterveneSujoy Dasgupta
Invited lecture by Dr Sujoy Dasgupta in a Webinar by Food, Drugs and Medicosurgical Equipment Committee of FOGSI (Federation of Obstetric and Gynaecological Societies of India) on “Adolescent Nutrition: Challenges and Way Forward” held in November, 2021.
Discover the 5 essential steps for menopause hormone therapy, including benefits, risks, and how to make informed decisions for a smoother transition through menopause.
Learn about the connection between Polycystic Ovary Syndrome (PCOS) and Metabolic Syndrome. Discover symptoms, associated risks, and effective management strategies to improve your health and well-being.
Late onset menopause, or delayed menopause, refers to the cessation of menstrual periods and reproductive function occurring at an older age than the average onset of menopause, which is typically around 51 years old. When menopause occurs after the age of 55, it is considered late onset. This phenomenon is relatively rare, affecting a small percentage of women, and is influenced by various factors including genetics, lifestyle, and environmental factors.
A urinary tract infection (UTI) during pregnancy occurs when bacteria enter the urinary tract, leading to an infection. This condition is relatively common during pregnancy due to hormonal changes that can affect the urinary system, as well as the physical changes that occur as the uterus expands and puts pressure on the bladder. UTIs in pregnancy require prompt attention and treatment to prevent complications for both the mother and the baby
Discover the essential steps and expert advice for optimal pre-conception care. Learn how to enhance your fertility, ensure a healthy pregnancy, and lay the foundation for your baby's lifelong well-being
Explore the intricacies of ovulation induction in intrauterine insemination (IUI) with Dr Laxmi Shrikhande's informative slide share presentation. From understanding the hormonal mechanisms to the latest techniques, this presentation offers insights into optimizing fertility through IUI. Whether you're a clinician seeking to enhance patient outcomes or an individual navigating fertility treatments, this resource provides valuable knowledge for your journey towards conception.
Discover the keys to maintaining optimal health and vitality during midlife with our comprehensive guide to nutrition. Learn about the dietary choices and habits that support physical well-being, cognitive function, and emotional balance as you navigate through this transformative stage of life. From nutrient-rich foods to mindful eating practices, empower yourself to thrive at midlife and beyond.
In this informative presentation, we delve into the complexities of fever during pregnancy. Pregnancy brings about various concerns, and fever can be particularly worrisome. Join us as we discuss the causes, potential risks, and necessary steps to take if you experience fever while pregnant. Our expert provides valuable insights and practical tips to ensure the safety and well-being of both mother and baby. Don't let uncertainty overwhelm you; empower yourself with knowledge about fever in pregnancy and learn what steps to take next. Watch now to gain the guidance you need for a healthy pregnancy journey.
Unlock the secrets to vibrant health and vitality during midlife with our comprehensive guide on nutrition tailored specifically for women. Discover expert advice, science-backed strategies, and practical tips to support hormonal balance, bone health, metabolism, and overall well-being. Whether you're navigating menopause or simply aiming to thrive in your prime years, this SlideShare presentation is your roadmap to achieving optimal nutrition and vitality in midlife
IVF Pregnancy -Is it different? A presentation by Dr Laxmi Shrikhande the leading IVF specialist in India
IVF (In Vitro Fertilization) pregnancy can be both similar to and different from natural conception in several ways. In IVF, fertilization of the egg occurs outside the body in a laboratory setting, typically involving the extraction of eggs from the ovaries and combining them with sperm in a petri dish. Once fertilization is successful, the resulting embryos are transferred to the uterus for implantation
Uterine Fibroids: Symptoms, Causes, Risk Factors & Treatment uterine fibroids aren't associated with an increased risk of uterine cancer and almost never develop into cancer
A benign tumor of muscular and fibrous tissues, typically developing in the wall of the uterus.
Prevalence varies among studies and countries (4.5-68.6%)
Nearly 20-30% Indian women in reproductive age group have fibroid uterus
At any given time, nearly 15-25 million Indian women have fibroid uterus
Understand fibroids in a better way
Non-Specific Musculoskeletal Pain presented by Dr.Laxmi Shrikhande Consultant –Shrikhande Hospital & Research Centre Pvt Ltd
Nagpur. The leading hospital in Nagpur
This presentation covers the
1)Pain
2)Characteristics
3) Causes
4) Symptoms
You can get the awareness that you were looking for Non Specific Musculoskeletal Pain details
Non-Specific Musculoskeletal Pain presented by Dr.Laxmi Shrikhande Consultant –Shrikhande Hospital & Research Centre Pvt Ltd
Nagpur. The leading hospital in Nagpur
This presentation covers the
1)Pain
2)Characteristics
3) Causes
4) Symptoms
Contraception where have we been and where are we going is a presentation made by Dr.Laxmi Shrikhande who is a Fertility Specialist, Laparoscopic Surgeon & no scar Hysterectomy Specialist and a leading Gynaecologist from Nagpur
Anti-Müllerian Hormone (AMH) is critical for physiologic involution of the Mullerian ducts during sexual differentiation in the male foetus.
In women,AMH is a product of the small antral follicles in the ovaries and serves to function as an autocrine and paracrine regulator of follicular maturation
Healthy Choices are the key!
Healthy diet including raw foods & avoiding processed food or high fat diet is the best way to eliminate toxins from your body. Toxins damage your egg follicles.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Immunity to Veterinary parasitic infections power point presentation
Diabetes in Pregnancy
1.
2. • Medical Director-Shrikhande Fertility Clinic, Nagpur
• Chairperson Designate ICOG 2020
• National Corresponding Editor-Journal of OB/GY of India JOGI
• National Corresponding Secretary AMWI
• Senior Vice President FOGSI 2012
• Founder Patron & President –ISOPARB Vidarbha Chapter
• Received Nagpur Ratan Award at the hands of Union Minister Shri
Nitinji Gadkari
• Received Bharat excellence Award for women’s health
• Received Mehroo Dara Hansotia Best Committee Award for her work as
Chairperson HIV/AIDS Committee, FOGSI
• Received appreciation letter from Maharashtra Government for her work
in the field of SAVE THE GIRL CHILD
• Immediate Past President Menopause Society, Nagpur
• President Nagpur OB/GY Society 2005-06
• Delivered 11 orations and 450 guest lectures
• Publications-Twenty National & Eleven International
• Sensitized 2 lakh boys and girls on adolescent health issues
Dr. Laxmi Shrikhande
Nagpur
5. Gestational diabetes
mellitus
Pre Existing Diabetes
Hyperglycemia during
pregnancy that is not
diabetes
Diagnosed before the
start of pregnancy OR
Hyperglycemia diagnosed for the
first time in pregnancy. Meets
WHO criterion for diabetes
mellitus in the nonpregnant
state
Hyperglycemia diagnosed for
the first time during
pregnancy
May occur any time during
pregnancy including the first
trimester
May occur any time during
pregnancy but most likely
>24 weeks
6. Prevalence
22 million women between 20-39 yrs have diabetes -2010 data
Expected to rise by 20% in next 10 years
54 million women with IGT or pre diabetes have the potential to develop
GDM if they become pregnant.
The prevalence of GDM in India varies from 3.8 to 21% in different parts
of the country, depending on the geographical locations and diagnostic
methods used.
GDM has been found to be more prevalent in urban areas than in rural
areas
8. Pathophysiology of GDM
Gestational
diabetes
mellitus
Insulin resistance
due to placental
secretion of anti-
insulin hormones
Maternal hepatic
glucose production
increases by 15%-
30% to meet fetal
demand late in
pregnancy Pancreatic -cell
dysfunction due to
• Genetics
• Autoimmune disorders
• Chronic insulin resistance
Inturrisi M, et al. Endocrinol Metab Clin N Am. 2011;40:703-726. Metzger BE, et al. Diabetes Care. 2007;30(2):S251-S260.
9. SCREENING VERSUS DIAGNOSTIC TESTING
The purpose of screening is to identify asymptomatic
individuals with a high probability of having or
developing a specific disease.
10. Whom to screen ?
Universal screening appears to be the optimum approach as
the Indian women have 11 fold increased risk of developing
glucose intolerance during pregnancy compared to
Caucasian women .
11. Which screening method ?
Diabetes in Pregnancy Study Group of India (DIPSI) Criteria
One step approach - The one step approach has been
proposed by the DIPSI and endorsed by the GOI .
On 14th March 2007, Government of India issued the
instructions that universal screening of glucose intolerance
during pregnancy should be mandatory.
The order recommends that all women should be screened
between 24 and 28 weeks of gestation with 2 h 75 g oral
glucose.
12. How to do it ?
75 gms glucose with 300 ml water
Irrespective of last meal
Ingestion to be completed within 5-10 min
Measure blood sugar after 2 hour
If vomiting within 30 min of intake-repeat test next day
14. Advantages of DIPSI Criteria
simple, feasible, convenient, economical and acceptable in Indian
scenario
In India, women have to travel long distances for check-up, hence
this non-fasting single test becomes more acceptable to the
pregnant women
Indian population is diverse and variable, hence international
criteria on Indian population may not be practical and feasible.
16. Why Diagnose and Treat GDM?
Identifying women with GDM is important because appropriate
therapy can decrease maternal and fetal morbidity .
Can prevent two generations from developing diabetes in the
future.
20. Outline for GDM management
Primary management strategy for GDM: dietary changes
and exercise
If uncontrolled hyperglycemia with lifestyle change:
Insulin should be first line therapy
Use Metformin, if insulin cannot be used
21. Management Issues-
Patient education
Medical Nutrition therapy
Pharmacological therapy
Glycemic monitoring: SMBG & Targets
Fetal monitoring: ultrasound
Planning on delivery
Postpartum care
22. GDM: Management During Pregnancy
Receive nutrition counseling by registered dietician to
achieve their nutrition, weight and blood glucose goals
Eat healthy diet and Replace high-Glycemic Index foods
with low-Glycemic Index foods to reduce need for insulin
initiation
Discuss appropriate weight gain and healthy lifestyle
interventions throughout pregnancy
23. Medical Nutrition Therapy (MNT)
Therapeutic goals:
adequate nutrition
Adequate weight gain
prevention of ketosis
Prevention of postprandial hyperglycemia.
25. GDM Diet
Diet- 30 kcal/kg – normal weight women, 24 Kcal/kg for overweight
women, and 12 Kcal/kg for morbidly obese women.
Diet should contain carbohydrate 50%, protein 20% and fat 25-30%.
Usually three meal regimen, with breakfast 25% of the total intake,
lunch 30%, dinner 30%.
26. Physical Activity
Unless contraindicated, physical activity should be included
in a pregnant woman’s daily regimen
Regular moderate-intensity physical activity (eg, walking)
can help to reduce glucose levels in patients with GDM
Other appropriate forms of exercise during pregnancy
Cardiovascular training with weight-bearing, limited to
the upper body to avoid mechanical stress on the
abdominal region
27. Target weight gain in GDM
Prepregnancy BMI Category Total weight gain
<18.5 Underweight 12.5-18 Kg
18.5-24.9 Normal weight 11.5-16 Kg
25-29.9 Overweight 7-11.5 Kg
>30 Obese 5-9 Kg
28. Insulin initiation during pregnancy
About 50% of women initially treated with diet alone will require
additional therapy, and insulin therapy usually is recommended.
Insulin management must be individualized, but most pregnant
women require about 0.7 units/kg daily.
two thirds of the insulin is administered in the morning and one
third is administered in the evening, with a 1:2 ratio of short- to
intermediate- (or long-) acting insulin.
Kahn, CR, King GL., Moses AC., . Joslin's Diabetes Mellitus (14th Edition).Weir GC., Jacobson AM., Smith RJ JOSLIN
DIABETES CENTER. Boston, Lippincott Williams & Wilkins, 2005, chapter 61
29.
30. Status of OHA in pregnancy
Metformin and the sulfonylurea glyburide are the 2 most commonly
prescribed oral antihyperglycemic agents during pregnancy
transfer category B, others
Due to efficacy and safety concerns, the ADA and DIPSI does not
recommend oral antihyperglycemic agents for gestational diabetes mellitus
(GDM) or preexisting T2DM
Medication Crosses Classification Notes
Placenta
Metformin Y
es Category B Metformin and glyburide may be
insufficient to maintain normoglycemia at
all times, particularly during postprandial
period
Glyburide Minimal Some formulations
category C
31. OHA in pregnancy
Metformin
Insulin sensitizer
Give with meal
Start at 500 mg once or twice daily with food
Increase slowly weekly to 2000 mg per day (2500 mg/day)
No teratogenic risks demonstrated
pregnancy risk factor: B (No evidence of risk in studies)
Not FDA approved for use in pregnancy
32. Monitoring Blood Glucose
At least 4 times-self monitoring
Fasting and 3 one and half hour postprandial
After achieving target level, lab monitoring till 28wks- once in
a month
28-32 weeks once in 2 weeks
>32 once a week
Other parameters to be monitored: fundus,micro albuminuria
33. Glycemic targets
Mean plasma glucose -105 mg/dl
maintaine FPG at 90 & PP at 120
Mean plasma glucose should never go below 86
38. Care in labour & delivery
Institutional delivery
Presence of expert obstetrician
Close electronic monitoring
39. Care in labour & delivery
Close monitoring in second stage
W/F foetal distress
Vaginal delivery should be preferred and LSCS should be done for obstetric indications only.
40. Insulin Management during Labour &
Delivery
Usual dose of intermediate-acting insulin is given at bedtime
Morning dose of insulin is withheld
I.V infusion of normal saline is begun
Once active labor begins or glucose levels fall below 70 mg/dl, infusion is
changed from saline to 5% dextrose & delivered at a rate of 2.5 mg/kg/min
Glucose levels are checked hourly using a portable meter allowing for
adjustment in infusion rate
Regular (short-acting) insulin is administered by iv infusion if glucose levels
exceed 140 mg/dl
41. Immediate postpartum care-
GDM on MNT
Cease blood glucose monitoring immediately after delivery
Regular postnatal care
OGTT 6 weeks postpartum
American Diabetes Association. Standards for medical care in diabetes 2018.
Diabetes Care 2018
42. Immediate postpartum care
GDM on OHAs
In most women, glucose tolerance will normalize immediately after delivery
Cease pharmacological therapy immediately after delivery
Continue pre prandial BGL monitoring QID for 24 hrs
If preprandial BGL 72 – 126mg/dl – discontinue monitoring
If BGL <72mg/dl or >126mg/dl – seek medical review and continue monitoring
1 – 8% may continue to be glucose intolerant and need OHAs
Metformin, glibenclamide / glyburide safe during lactation
Queensland clinical guideline 2015
43. Preprandial BGL monitoring QID for 24 hrs
If BGL >126mg/dl –medical review & start OHAs
Insulin therapy is generally not indicated unless marked
fasting hyperglycemia (200–250 mg/dL)
Queensland clinical guideline 2015
Immediate postpartum care
GDM on Insulin
44. Risk factors for persistent diabetes
Pregnancy fasting glucose levels greater than or equal to 126 mg/dL
Diagnosis of GDM during the first trimester
A prior history of GDM without documented normal glucose
tolerance outside of pregnancy
Metzger BE. Summary and recommendations of the 4th International Workshop-
Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21(Suppl 2):B1617.
45. Monitor for persistent diabetes
Recommend OGTT at 6 weeks postpartum to screen for persistant
diabetes
Recommend lifelong screening for diabetes every 3 yrs
Early glucose monitoring in future pregnancy
46. Breast feeding
should be encouraged to breastfeed immediately after delivery
in order to avoid neonatal hypoglycemia [Grade D, Consensus]
and
to continue for at least 3-4 months postpartum in order to
prevent childhood obesity [Grade C, Level 3] and diabetes in
the offspring [Grade D, Level 4] and
to reduce risk of type 2 diabetes and hypertension in the
mother [Grade C, Level 3]
48. Can we Prevent GDM ?
In women at high risk for GDM based on pre-
existing risk factors, nutrition counseling should
be provided on healthy eating and prevention of
excessive gestational weight gain in early
pregnancy, ideally before 15 weeks of gestation,
to reduce the risk of GDM [Grade B, Level 2]
49. Key points
Universal testing of all pregnant women for GDM
Testing recommended twice in pregnancy; at 1st antenatal visit and then at 24-28 weeks of gestation. DIPSI
recommends additional screening at ~34 weeks.
Single step 75 gm 2 hr OGTT test performed.
Pregnant women testing positive(2hr OGTT≥140mg/dL) should be started on MNT for 2 weeks.
If 2 hr PPBS ≥120 mg/dL after MNT and physical exercise, medical management (metformin or insulin therapy) of
pregnant women to be started as per guidelines.
Early delivery with administration of prophylactic corticosteroid therapy for fetal lung maturity to be planned only if
uncontrolled blood sugar or any other obstetric indication
Vaginal delivery preferred, LSCS for only obstetric indications or fetal macrosomia.
Neonatal monitoring for hypoglycemia and other complications
Postpartum evaluation of glycemic status by a 75 g OGTT at 6 weeks after delivery.